打破前列腺癌的障碍:mRNA疫苗的突破以及接下来会发生什么
Rayan Rajabi1, Somayeh Vafaei2, Fatemeh Afrashteh3
1Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran.
NPJ vaccines
|January 6, 2026
概括
使者RNA (mRNA) 疫苗代表了前列腺癌 (PC) 的新型免疫疗法. 本综述强调了它们的潜力,早期试验结果以及克服个性化PC治疗挑战的策略.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 疫苗技术技术 疫苗技术
背景情况:
- 传统的前列腺癌 (PC) 治疗有局限性.
- 新兴的免疫疗法为PC提供了新的治疗途径.
- 使者RNA (mRNA) 技术为癌症疫苗提供了一个有前途的平台.
研究的目的:
- 审查基于mRNA的疫苗在前列腺癌免疫治疗中的潜力.
- 讨论PC的mRNA疫苗的机制,生产,安全性和临床试验结果.
- 确定开发个性化mRNA癌症疫苗的挑战和进展.
主要方法:
- 关于mRNA疫苗技术和前列腺癌研究的文献综述.
- 对基于mRNA的PC疫苗 (例如CV9103/4) 的早期临床试验数据的分析.
- 检查克服挑战的策略,如抗原选择和瘤微环境.
主要成果:
- mRNA疫苗显示出作为前列腺癌新型免疫疗法的潜力.
- 早期临床试验显示,针对特定的mRNA疫苗候选人的安全性和有效性概况有希望.
- 输送系统 (脂质纳米颗粒) 和组合疗法的进步正在提高疫苗的有效性.
结论:
- mRNA疫苗是前列腺癌快速发展和有前途的免疫疗法.
- 解决抗原选择和瘤微环境等挑战对于优化疗效至关重要.
- 个性化mRNA疫苗,可能与检查点抑制剂相结合,代表了先进的PC治疗的未来.
更多相关视频
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
7.2K
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
17.1K
相关概念视频
Cancer Vaccines
946
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
946
Microorganisms in Medicine and Therapeutics
928
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
928
Rous Sarcoma Virus (RSV) and Cancer
6.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.2K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
